Email this article 
Analysis of the efficiency of colorectal cancer diagnostics in patients with malignant neoplasms detected for the first time
- Authors: Naygovzina N.B.1, Patrushev M.A.1
- Affiliations:
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Issue: No 2 (2023)
- Pages: 113-117
- Section: Articles
- URL: https://remedium-journal.ru/journal/article/view/1623
- DOI: https://doi.org/10.32687/1561-5936-2023-27-2-113-117
- Cite item
Abstract
This article presents an analysis of the routing of patients in the diagnosis of malignant neoplasms of colorectal localization based on the data of primary medical documentation at the place of diagnosis and retrospectively in outpatient facilities during preventive examinations and medical examinations.
About the authors
Nelli B. Naygovzina
A. I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
Email: nnb@koziz.ru, https://orcid.org/0000-0001-9479-9084
Mikhail A. Patrushev
A. I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
Email: 002
References
- Kaprin A. D. et al. (eds.) Malignant neoplasms in Russia in 2019 (morbidity and mortality). Moscow; 2020. 252 p.; 2. Nesterov P. V., Ukharskiy A. V., Kislov N. V. Regional clinical and economic model of colorectal cancer screening. Research and Practical Medicine Journal. 2020;7(3):146—159. doi: 10.17709/2409-2231-2020-7-3-15 (In Russ.); 3. Jahn B., Sroczynski G., Bundo M. et al. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria. BMC Gastroenterol. 2019;19:209. doi: 10.1186/s12876-019-1121-y; 4. Worthington J., Lew J. B., Feletto E. et al. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment. PLoS One. 2020;15(2):e0227899. doi: 10.1371/journal.pone.0227899
